Recombinant Activated Factor VII Combined with Desmopressin in Preventing Bleeding from Dental Extraction in a Patient with Glanzmann’s Thrombasthenia

Abstract

The case of a 41-year-old woman with Glanzmann’s thrombasthenia who underwent double dental extraction is presented. In the past, treatments with desmopressin (DDAVP) and tranexamic acid had often unsuccessful efficacy to stop or decrease bleeding. After ineffective DDAVP administration, the removal was performed successfully with recombinant activated factor VII (rFVIIa) infusion. rFVIIa infusion after DDAVP administration could be useful in patients with Glanzmann’s thrombasthenia in which DDAVP and tranexamic acid weren’t always effective.

Keywords

Glanzmann’s thrombasthenia Dental extraction Recombinant activated factor VII

References

George JN , Caen JP , Nurden AT . Glanzmann’s thrombasthenia: The spectrum of clinical disease. Blood 1990;75(7):1383.

Bell JA , Savidge GF . Glanzmann’s thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost 2003;9(2):167.

Rao AK , Gosh S , Sun L , et al. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial. Thromb Haemost 1995;74(4):1071.

Mannucci PM . Desmopressin (DDAVP) in the treatment of bleeding disorders; the first twenty years. Haemophilia 2000;6(Suppl 1):60.

Galan AM , Tonda R , Pino M , et al. Increased local procoagulant action: A mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion 2003;43(7):885.

Laurian Y . Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 2002;32(Suppl 1):37.

Poon MC , D’Oiron R , Von Depka M , et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann’s thrombasthenia: Results of an international survey. J Thromb Haemost 2004;2(7):1096.